The Commissions proposal for a European Biotech Act I represents a significant opportunity to promote the use of non-animal methods and transition to health research and innovation that does no longer rely on animal use, in line with the recent roadmap published by the EC on phasing out animal testing for chemical safety assessments and the European Research Area action on New Approach Methodologies.
TRA
transcience
NGO · France
2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track transcience in PolicySpeak: request access →
Work at transcience? so we know who speaks for it.
Their record over time
transcience filed 2 positions between 2 Dec 2025 and 31 Jul 2026, across 2 of the 326 legislative files tracked here.
2025 · 1 filed2026 · 1 filed
What they argued
We wish to emphasize the importance of the objective of transitioning to non-animal chemical safety assessment, in line with the roadmap toward phasing out animal testing, currently being finalized, and the 2021 Parliamentary resolution. This means integrating non-animal approaches into overall strategy, annual programming and resource allocation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- Cefic · 2 files in common
- Wirtschaftskammer Österreich · 2 files in common
- Japan Business Council in Europe · 2 files in common
- German Association of Biotechnology Industries (DIB) within the German Chemical Industry Association - VCI · 2 files in common
- Eurogroup for Animals · 2 files in common
Showing 5 of 14.
Is this your organization?
Everything on this page comes from transcience’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.